Bio

Honors & Awards


  • Doris Duke Clinical Research Fellowship, Doris Duke Charitable Foundation (2012-2013)
  • The Rotary Foundation Ambassadorial Scholarship, Rotary International (2011-2012)
  • Stanford Medical Scholars Grant, Stanford Medical Scholars Research Program (2009-2010, 2012-2013)
  • The Harvey Cushing Fellowship in Science, The Kingsley Trust Association and Yale University (2006)

Education & Certifications


  • Bachelor of Science, Yale University, Biophysics and Biochemistry (2008)
  • Master of Philosophy, University of Cambridge, Epidemiology (2012)

Publications

Journal Articles


  • Patient-reported problems after office procedures. JAMA internal medicine Linos, E., Wehner, M. R., Frosch, D. L., Walter, L., Chren, M. M. 2013; 173 (13): 1249-50

    View details for PubMedID 23689235

  • Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis BRITISH MEDICAL JOURNAL Wehner, M. R., Shive, M. L., Chen, M., Han, J., Qureshi, A. A., Linos, E. 2012; 345

    Abstract

    To synthesise the literature on indoor tanning and non-melanoma skin cancer.Systematic review and meta-analysis.PubMed (1966 to present), Embase (1974 to present), and Web of Science (1898 to present).All articles that reported an original effect statistic for indoor tanning and non-melanoma skin cancer were included. Articles that presented no data, such as review articles and editorials, were excluded, as were articles in languages other than English.Two investigators independently extracted data. Random effects meta-analysis was used to summarise the relative risk of ever use versus never use of indoor tanning. Dose-response effects and exposure to indoor tanning during early life were also examined. The population attributable risk fraction for the United States population was calculated.12 studies with 9328 cases of non-melanoma skin cancer were included. Among people who reported ever using indoor tanning compared with those who never used indoor tanning, the summary relative risk for squamous cell carcinoma was 1.67 (95% confidence interval 1.29 to 2.17) and that for basal cell carcinoma was 1.29 (1.08 to 1.53). No significant heterogeneity existed between studies. The population attributable risk fraction for the United States was estimated to be 8.2% for squamous cell carcinoma and 3.7% for basal cell carcinoma. This corresponds to more than 170?000 cases of non-melanoma skin cancer each year attributable to indoor tanning. On the basis of data from three studies, use of indoor tanning before age 25 was more strongly associated with both squamous cell carcinoma (relative risk 2.02, 0.70 to 5.86) and basal cell carcinoma (1.40, 1.29 to 1.52).Indoor tanning is associated with a significantly increased risk of both basal and squamous cell skin cancer. The risk is higher with use in early life (<25 years). This modifiable risk factor may account for hundreds of thousands of cases of non-melanoma skin cancer each year in the United States alone and many more worldwide. These findings contribute to the growing body of evidence on the harms of indoor tanning and support public health campaigns and regulation to reduce exposure to this carcinogen.

    View details for DOI 10.1136/bmj.e5909

    View details for Web of Science ID 000309659300001

    View details for PubMedID 23033409

  • Itch as a patient-reported symptom in ambulatory care visits in the United States JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Shive, M., Linos, E., Berger, T., Wehner, M., Chren, M. 2013; 69 (4): 550-556

    Abstract

    European studies have shown that itch is a widespread symptom, yet little is known about its frequency in the United States.We sought to describe ambulatory care visits to clinicians in the United States for which itch was coded as a patient symptom.This study uses retrospective data from the National Ambulatory Medical Care Survey from 1999 through 2009.Itch was coded as a symptom for an average of 7 million visits per year or approximately 1% of all outpatient visits, which was nearly 40% of the number of visits for the symptom of low back pain. Patients seen in visits for itch were more likely to be black or Asian than other patients (20% vs 14%). They were also more likely than other patients to receive a new medication (68% vs 36%) and were over twice as likely to receive 2 or more new medications (31% vs 14%).Secondary data sets may not optimally capture patient reports and some of the procedures or medications may have been ordered for reasons other than itch.Visits to clinicians for itch represent a sizeable proportion of ambulatory care visits in the United States, and research on the epidemiology, treatments, and causes of itch should be a priority.

    View details for DOI 10.1016/j.jaad.2013.05.029

    View details for Web of Science ID 000324238900036

    View details for PubMedID 23870201

  • A novel mouse model for frostbite injury. Wilderness & environmental medicine Auerbach, L. J., Galvez, M. G., De Clerck, B. K., Glotzbach, J., Wehner, M. R., Chang, E. I., Gurtner, G. C., Auerbach, P. S. 2013; 24 (2): 94-104

    Abstract

    Frostbite injury occurs when exposure to cold results in frozen tissue. To screen drugs and other field therapies that might improve the outcome for a frostbite victim, it would be helpful to have a reliable and cost-effective preclinical in vivo model.We sought to create a novel mouse skin model of induced frostbite injury. This model would allow quantification of the surface area of involved skin, histology of the wound, rate of wound healing, and skin loss in a standardized fashion after the frostbite injury.Thirty-six mice were studied. Standardized 2.9-cm diameter circles were tattooed on the mouse dorsum. Magnets frozen in dry ice (-78.5°C) were used to create a frostbite injury on skin within the circle, either as a continuous 5-minute freeze or as 3 repeated freeze (1-minute) and thaw (3-minute) cycles. Appearance, healing rate, skin surface area loss, and histology were recorded until the wounds were healed.The amount of skin surface area loss was approximately 50% for both freeze methods. Although the time to surface skin healing was similar for both freeze methods, the initial healing rate was significantly (P = .001) slower in mice exposed to the freeze-thaw cycles compared with the continuous freeze model. Histopathology reflected inflammatory changes, cell death, and necrosis.This novel in vivo mouse model for frostbite allows quantification of affected skin surface area, histology, healing rate, and skin loss and has the potential of being utilized to screen future treatment modalities.

    View details for DOI 10.1016/j.wem.2012.11.020

    View details for PubMedID 23481507

  • Usefulness of the Addition of Beta-2-Microglobulin, Cystatin C and C-Reactive Protein to an Established Risk Factors Model to Improve Mortality Risk Prediction in Patients Undergoing Coronary Angiography AMERICAN JOURNAL OF CARDIOLOGY Nead, K. T., Zhou, M. J., Caceres, R. D., Sharp, S. J., Wehner, M. R., Olin, J. W., Cooke, J. P., Leeper, N. J. 2013; 111 (6): 851-856

    Abstract

    Evidence-based therapies are available to reduce the risk for death from cardiovascular disease, yet many patients go untreated. Novel methods are needed to identify those at highest risk for cardiovascular death. In this study, the biomarkers ?2-microglobulin, cystatin C, and C-reactive protein were measured at baseline in a cohort of participants who underwent coronary angiography. Adjusted Cox proportional-hazards models were used to determine whether the biomarkers predicted all-cause and cardiovascular mortality. Additionally, improvements in risk reclassification and discrimination were evaluated by calculating the net reclassification improvement, C-index, and integrated discrimination improvement with the addition of the biomarkers to a baseline model of risk factors for cardiovascular disease and death. During a median follow-up period of 5.6 years, there were 78 deaths among 470 participants. All biomarkers independently predicted future all-cause and cardiovascular mortality. A significant improvement in risk reclassification was observed for all-cause (net reclassification improvement 35.8%, p = 0.004) and cardiovascular (net reclassification improvement 61.9%, p = 0.008) mortality compared to the baseline risk factors model. Additionally, there was significantly increased risk discrimination with C-indexes of 0.777 (change in C-index 0.057, 95% confidence interval 0.016 to 0.097) and 0.826 (change in C-index 0.071, 95% confidence interval 0.010 to 0.133) for all-cause and cardiovascular mortality, respectively. Improvements in risk discrimination were further supported using the integrated discrimination improvement index. In conclusion, this study provides evidence that ?2-microglobulin, cystatin C, and C-reactive protein predict mortality and improve risk reclassification and discrimination for a high-risk cohort of patients who undergo coronary angiography.

    View details for DOI 10.1016/j.amjcard.2012.11.055

    View details for Web of Science ID 000316537700013

    View details for PubMedID 23290308

  • Transgenic Mice Lacking Serotonin Neurons Have Severe Apnea and High Mortality during Development JOURNAL OF NEUROSCIENCE Hodges, M. R., Wehner, M., Aungst, J., Smith, J. C., Richerson, G. B. 2009; 29 (33): 10341-10349

    Abstract

    Central serotonin (5-HT) neurons modulate many vital brain functions, including respiratory control. Whether breathing depends critically on 5-HT neurons, or whether their influence is excitatory or inhibitory, remains controversial. Here we show that neonatal Lmx1b(flox/flox;ePet-Cre/+) mice (also called Lmx1b(f/f/p) mice), which selectively lack serotonin neurons, display frequent and severe apnea lasting as long as 55 s. This was associated with a marked decrease in ventilation to less than one-half of normal. These respiratory abnormalities were most severe during the postnatal period, markedly improving by the time the pups were 2-4 weeks old. Despite the severe breathing dysfunction, many of these mice survived, but there was a high perinatal mortality, and those that survived had a decrease in growth rate until the age at which the respiratory defects resolved. Consistent with these in vivo observations, respiratory output was markedly reduced in isolated brainstem-spinal cord preparations from neonatal Lmx1b(f/f/p) mice and completely blocked in perfused brain preparations from neonatal rats treated with selective antagonists of 5-HT(2A) and neurokinin 1 (NK-1) receptors. The ventilatory deficits in neonatal Lmx1b(f/f/p) mice were reversed in vitro and in vivo with agonists of 5-HT(2A) and/or NK-1 receptors. These results demonstrate that ventilatory output in the neonatal period is critically dependent on serotonin neurons, which provide excitatory drive to the respiratory network via 5-HT(2A) and NK-1 receptor activation. These findings provide insight into the mechanisms of sudden infant death syndrome, which has been associated with abnormalities of 5-HT neurons and of cardiorespiratory control.

    View details for DOI 10.1523/JNEUROSCI.1963-09.2009

    View details for Web of Science ID 000269087300017

    View details for PubMedID 19692608

  • Supercontinuum Generation in Sub-Centimeter Lengths of High-Nonlinearity Photonic Crystal Fibers. Optics & Photonics News F. Omenetto, N. Wolchover, M. Wehner, M. Ross, A. Efimov, A. Taylor, V. Kumar, A. George, J. Knight, N. Joly, P. Russell 2006; 17 (12): 35-35
  • Spectrally Smooth Supercontinuum from 350 nm to 3 &#956;m in Sub-Centimeter Lengths of Soft-Glass Photonic Crystal Fibers. Optics Express F. Omenetto, N. Wolchover, M. Wehner, M. Ross, A. Efimov, A. Taylor, V. Kumar, A. George, J. Knight, N. Joly, P. Russell 2006; 14 (11): 4928-4934

Stanford Medicine Resources: